$126.34
1.26% yesterday
NYSE, Oct 23, 10:12 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$126.34
-9.55 7.03% 1M
-3.50 2.70% 6M
+13.23 11.70% YTD
+9.33 7.97% 1Y
+28.05 28.54% 3Y
+18.55 17.21% 5Y
+82.74 189.77% 10Y
+105.81 515.50% 20Y
NYSE, Closing price Thu, Oct 23 2025
-1.61 1.26%

Key metrics

Basic
Market capitalization
$219.9b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
15.8 | 24.3
P/S
5.0 | 4.9
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$2.24
Yield 1Y | 5Y
1.8% | 1.8%
Growth 1Y | 5Y
7.7% | 11.2%
Payout 1Y | 3Y
29.2% | 42.0%
Increased
11 Years
Financials (TTM | estimate)
Revenue
$43.8b | $45.1b
EBITDA
$9.7b | $12.0b
EBIT
$8.0b | $10.5b
Net Income
$14.0b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
6.4% | 7.6%
EBITDA
10.0% | 35.6%
EBIT
15.2% | 50.6%
Net Income
142.4% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
56.2%
EBITDA
22.2% | 26.6%
EBIT
18.3%
Net
31.9% | -
Free Cash Flow
-
Financial Health
Equity Ratio
58.6%
Return on Equity
28.1%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
$8.0
FCF per Share
-
Short interest
1.1%
Employees
114k
Rev per Employee
$370.0k
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,021 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

35 Analysts have issued a Abbott Laboratories forecast:

23x Buy
66%
12x Hold
34%

Analyst Opinions

35 Analysts have issued a Abbott Laboratories forecast:

Buy
66%
Hold
34%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
43,843 43,843
6% 6%
100%
- Direct Costs 19,209 19,209
5% 5%
44%
24,634 24,634
7% 7%
56%
- Selling and Administrative Expenses 12,021 12,021
5% 5%
27%
- Research and Development Expense 2,867 2,867
8% 8%
7%
9,746 9,746
10% 10%
22%
- Depreciation and Amortization 1,725 1,725
9% 9%
4%
EBIT (Operating Income) EBIT 8,021 8,021
15% 15%
18%
Net Profit 13,977 13,977
142% 142%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
Reuters
3 days ago
Walmart will become the first U.S. retailer to sell an over-the-counter continuous glucose monitor in physical stores, as Abbott Laboratories' Lingo rolls out to more than 3,500 locations and online, Axios reported on Tuesday, citing the medical device maker.
Positive
Seeking Alpha
6 days ago
The market has overreacted to ABT's lowered FY2025 organic sales growth/narrowed adj. EPS, since the management continues to deliver robust numbers while building upon FY2024 outperformance. Much of its tailwinds are attributed to the robust demand for its diabetes care offerings across continuous glucose monitors and Adult Nutrition, thanks to the ongoing GLP-1 boom. ABT has also been driving ...
Negative
MarketBeat
7 days ago
Abbott Laboratories' NYSE: ABT October price plunge is a signal to buy, as analyst and institutional trends suggest they, too, will be buying the stock. Analyst trends revealed by MarketBeat data include increasing coverage with newly initiated ratings appearing within days of the Q3 earnings release.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today